These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Operative hysteroscopy in the minimally invasive management of interstitial pregnancy and interstitially retained products of conception: A case report and systematic literature review. D'hoore E; D'hoore L; Van den Berghe S; Roets E; van Wessel S; Hamerlynck T Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():54-59. PubMed ID: 34428687 [TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of placenta accreta. Hatfield JL; Brumsted JR; Cooper BC J Minim Invasive Gynecol; 2006; 13(6):510-3. PubMed ID: 17097571 [TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report. Alonso L; Nieto L; Carugno J J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480 [TBL] [Abstract][Full Text] [Related]
7. Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome. Tavcar J; Movilla P; Carusi DA; Loring M; Reddy H; Isaacson K; Morris SN J Minim Invasive Gynecol; 2023 Mar; 30(3):192-198. PubMed ID: 36442752 [TBL] [Abstract][Full Text] [Related]
8. High-intensity focused ultrasound versus uterine artery embolization for patients with retained placenta accreta. Jiang J; Wang C; Xue M Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():82-86. PubMed ID: 32590166 [TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic management of retained products of conception: A systematic review. Taylor C; Ellett L; Hiscock R; Mooney S Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):22-32. PubMed ID: 34751942 [TBL] [Abstract][Full Text] [Related]
10. Two-step hysteroscopy for management of morbidly adherent retained products of conception. Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494 [TBL] [Abstract][Full Text] [Related]
11. Early versus late hysteroscopic resection after high-intensity focused ultrasound for retained placenta accreta. He S; Xue M; Jiang J Int J Hyperthermia; 2021; 38(1):257-262. PubMed ID: 33612042 [No Abstract] [Full Text] [Related]
12. Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention. Guarino A; Di Benedetto L; Assorgi C; Rocca A; Caserta D Int J Clin Exp Pathol; 2015; 8(10):13625-9. PubMed ID: 26722586 [TBL] [Abstract][Full Text] [Related]
13. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications. Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362 [TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta. Ye M; Yin Z; Xue M; Deng X BJOG; 2017 Aug; 124 Suppl 3():71-77. PubMed ID: 28856861 [TBL] [Abstract][Full Text] [Related]
15. Reproductive and Obstetric Outcomes After Hysteroscopic Removal of Retained Products of Conception. van Wessel S; Coryn N; van Vliet H; Schoot B; Weyers S; Hamerlynck T J Minim Invasive Gynecol; 2020; 27(4):840-846. PubMed ID: 31352066 [TBL] [Abstract][Full Text] [Related]
16. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808 [TBL] [Abstract][Full Text] [Related]
17. Is the cold loop hysteroscopic technique a myometrial sparing treatment for placenta accreta residuals in a puerperal uterus? Mazzon I; Favilli A; Grasso M; Horvath S; Gerli S J Matern Fetal Neonatal Med; 2016; 29(10):1613-6. PubMed ID: 26212585 [TBL] [Abstract][Full Text] [Related]
18. Delayed hysteroscopic resection of retained tissues and uterine conservation after conservative treatment for placenta accreta. Hequet D; Morel O; Soyer P; Gayat E; Malartic C; Barranger E Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):580-3. PubMed ID: 24138386 [TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for obstetric outcomes after hysteroscopic adhesiolysis for Asherman syndrome: A retrospective cohort study. Zhang Y; Zhu X; Zhang T; Zhang Y; Zhang M; Lin X Int J Gynaecol Obstet; 2022 Jan; 156(1):89-94. PubMed ID: 33483955 [TBL] [Abstract][Full Text] [Related]